sb 203580 has been researched along with Graft vs Host Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, XC; Li, XY; Tang, RX; Zeng, LY; Zhang, CP; Zheng, KY | 1 |
Li, Q; Li, WM; Zhang, J; Zou, P | 1 |
2 other study(ies) available for sb 203580 and Graft vs Host Disease
Article | Year |
---|---|
[Effects of p38MAPK inhibitor on the occurrence of acute GVHD and intestine damage after allogeneic hematopoietic stem cell transplantation in mice].
Topics: Animals; Apoptosis; Bone Marrow Transplantation; Fas Ligand Protein; fas Receptor; Graft vs Host Disease; Imidazoles; Intestines; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; p38 Mitogen-Activated Protein Kinases; Pyridines; Signal Transduction; Transplantation, Homologous | 2013 |
[Pathogenetic role of tissue factor in endothelial-injury in graft-versus-host disease].
Topics: Animals; Anthracenes; Cells, Cultured; Disease Models, Animal; Endothelial Cells; Endothelium; Endothelium, Vascular; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Imidazoles; Interferon-gamma; Interleukin-6; Mice; Mitogen-Activated Protein Kinases; Pyridines; T-Lymphocytes; Thromboplastin; Tumor Necrosis Factor-alpha | 2009 |